VYCO (Vycor Medical) FCF Yield %: 4.91 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vycor Medical FCF Yield %?

Vycor Medical VYCO FCF Yield % is 4.91 as of Jul. 21, 2026. The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Vycor Medical ranks better than 81.36% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Vycor Medical's Trailing 12-Month Free Cash Flow is $0.11 Mil, and Market Cap is $2.30 Mil. Therefore, Vycor Medical's FCF Yield % for today is 4.91%.

The historical rank and industry rank for Vycor Medical's FCF Yield % or its related term are showing as below:

VYCO' s FCF Yield % Range Over the Past 10 Years
Min: -35.5   Med: -3.72   Max: 5.94
Current: 4.91


During the past 13 years, the highest FCF Yield % of Vycor Medical was 5.94%. The lowest was -35.50%. And the median was -3.72%.

VYCO's FCF Yield % is ranked better than
81.36% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: -0.44 vs VYCO: 4.91

Vycor Medical's FCF Margin % for the quarter that ended in Mar. 2026 was 21.57%.


Vycor Medical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Vycor Medical FCF Yield % Related Terms


Vycor Medical FCF Yield % Historical Data

* Premium members only.

The historical data trend for Vycor Medical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vycor Medical FCF Yield % Chart

Vycor Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.56 -7.51 0.79 2.36 -0.45

Vycor Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.00 4.26 -4.93 3.86 13.18

VYCO vs AEMD, VTAK, ALURD: FCF Yield % Comparison

For the Medical Devices subindustry, Vycor Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vycor Medical FCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Vycor Medical's FCF Yield % falls into.



Vycor Medical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Vycor Medical's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.018 / 4.038133
=-0.45%

Vycor Medical's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.099 * 4 / 3.00357
=13.18%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 4.91 mean?
Vycor Medical (VYCO) has a FCF Yield % of 4.91 as of Jul. 21, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Vycor Medical and its competitors. According to the industry distribution chart, Vycor Medical ranks #159 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 18.6%.
Is Vycor Medical's FCF Yield % too high?
Vycor Medical's current FCF Yield % is 4.91. Based on the distribution chart, Vycor Medical ranks #159 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Vycor Medical's FCF Yield % compare to AEMD and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vycor Medical ranks #159 out of 853 companies for FCF Yield %. This places Vycor Medical in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Vycor Medical and its competitors. Vycor Medical's current FCF Yield % is 4.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.12, compared to a current price of $0.07 — trading 42.5% below its estimated fair value. The current FCF Yield % is 4.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Vycor Medical (VYCO), the current FCF Yield % is 4.91 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vycor Medical Business Description

Address 951 Broken Sound Boulevard, Suite 320, Boca Raton, FL, USA, 33487
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.